AbbVie, Pfizer gain FDA OK for novel antibiotic
Bio Pharma Dive
FEBRUARY 10, 2025
The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.
Mon.Feb 10, 2025
255 
Fourth person receives eGenesis’ gene-edited pig kidney transplant
Pharmaceutical Technology
FEBRUARY 10, 2025
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Axsome secures top drug’s future with Teva patent settlement
Bio Pharma Dive
FEBRUARY 10, 2025
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.
Super Bowl ad for copycat weight loss drugs stokes pharma power debate
Pharmaceutical Technology
FEBRUARY 10, 2025
Controversy surrounded Him & Hers commercial, called Sick of the System, in the lead up to Americas biggest sporting event.
Running Decentralized Trials at Scale: Planning for Success
Advertisement
There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.
Pliant shares collapse as company halts fibrosis drug study
Bio Pharma Dive
FEBRUARY 10, 2025
In what one analyst called a “unique situation,” the company stopped dosing patients on the recommendation of trial monitors, but doesn’t yet know what led to their decision.
Eton secures US patent for diabetes insipidus treatment
Pharmaceutical Technology
FEBRUARY 10, 2025
Eton has secured a patent from the USPTO for its ET-600 product candidates desmopressin oral solution formulation for diabetes insipidus.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Vertex COO Arbuckle to step down later this year
Bio Pharma Dive
FEBRUARY 10, 2025
Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex launches two important new medicines.
Boehringer seeks approval of lung disease drug after second Phase III success
Pharmaceutical Technology
FEBRUARY 10, 2025
Nerandomilast is posed to be Boehringer Ingelheims successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
The role of diagnostics in advancing antibody-drug conjugates
Bio Pharma Dive
FEBRUARY 10, 2025
Antibody-drug conjugates (ADCs) are revolutionizing oncology, but success requires precision diagnostics.
Public health strategies skip patients with rare diseases, says UK study
Pharmaceutical Technology
FEBRUARY 10, 2025
A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the general population.
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
Hemgenix shows efficacy among haemophilia B patients
Pharma Times
FEBRUARY 10, 2025
CSL Behring's study reveals significant long-term benefits
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
Pharmaceutical Technology
FEBRUARY 10, 2025
China's NMPA has granted approval for Keymed Biosciences supplemental NDA of Stapokibart to treat seasonal allergic rhinitis.
Capgemini unveils AI breakthrough to boost bioeconomy
Pharma Times
FEBRUARY 10, 2025
New methodology may boost innovation in protein engineering
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
Pharmaceutical Technology
FEBRUARY 10, 2025
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g
FDA clears new antibiotic for superbug infections
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
Boehringer seeks approval of lung disease drug after second Phase III success
Pharmaceutical Technology
FEBRUARY 10, 2025
Nerandomilast is posed to be Boehringer Ingelheims successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
Share in cystic fibrosis firm Sionna rise sharply after IPO
pharmaphorum
FEBRUARY 10, 2025
Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.
The Prominence of Pharmacy Deserts
Pharmaceutical Commerce
FEBRUARY 10, 2025
How chain and local closures are impacting healthcare access.
Pliant slumps on decision to pause lung disease drug trial
pharmaphorum
FEBRUARY 10, 2025
Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.
Pharma Pulse 2/10/25: AI Drug Discovery Impact on the Pharma Value Chain, Dementia Is Common and Somewhat Treatable & more
Pharmaceutical Commerce
FEBRUARY 10, 2025
The latest news for pharma industry insiders.
Balancing innovation and efficiency in clinical trials: Is there a middle ground?
pharmaphorum
FEBRUARY 10, 2025
Balancing innovation and efficiency in clinical trials is crucial for advancements in healthcare. This article explores the importance of finding a middle ground between innovative practices and efficient processes in clinical research.
Tackling Gaps in Manufacturing, Funding, and Expertise
Pharmaceutical Commerce
FEBRUARY 10, 2025
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the challenges associated with meeting the FDAs 2025 CGT forecasted approval goal.
Industry steps up as EU debates an action plan for AI
pharmaphorum
FEBRUARY 10, 2025
Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI
PHC, CCRM Partner up on Furthering Cell and Gene Therapy Development
Pharmaceutical Commerce
FEBRUARY 10, 2025
The agreement is centered around improving cell culture efficiency and CGT quality.
Tamil Nadu State Pharmacy Council to hold council election in June
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 10, 2025
The Tamil Nadu State Pharmacy Council (TN SPC) has decided to hold the 9th council election in the month of June, and a schedule of election processes was prepared and sent to the government for gazette notification.
Streamlining the Generic Drug Supply Chain: Best Practices
Drug Patent Watch
FEBRUARY 10, 2025
Streamlining the Generic Drug Supply Chain: Best Practices to Improve Efficiency and Patient Access As the generic drug industry continues to grow, it's becoming increasingly clear that the traditional supply chain model is no longer sustainable. With the rise of complex generics, regulatory pressures, and increasing demand for affordable medicines, it's time to rethink the way we approach the generic drug supply chain.
Top 20 Publicly Traded Pharma and Biotech Companies by Market Cap in 2025
XTalks
FEBRUARY 10, 2025
In an industry defined by innovation and evolving market dynamics, the pharma and biotech sector continues to drive growth and transformation. Market capitalization remains a critical barometer for gauging investor confidence and the financial robustness of companies driving breakthroughs in patient care. This roundup spotlights the top 20 publicly traded pharma and biotech companies based on their market cap in 2025, offering insights into the financial achievements and strategic initiatives th
Next-Generation Brand Planning: (Unexpected) Worrying Trends Demand a Rethink on Brand Planning
Intouch Solutions
FEBRUARY 10, 2025
In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning.
Beta Bionics’ $234.6M IPO Will Help Launch Next-Gen Diabetes Devices
XTalks
FEBRUARY 10, 2025
Beta Bionics, maker of the iLet bionic pancreas system, has successfully closed its upsized initial public offering (IPO), raising $234.6 million. The offering included the sale of 13,800,000 shares at $17.00 per share , with the full exercise of the underwriters option to purchase an additional 1,800,000 shares. The shares began trading on Nasdaq under the ticker symbol BBNX on January 30, 2025.
DDW Highlights: 10 February 2025
Drug Discovery World podcast
FEBRUARY 10, 2025
The latest episode of the DDW Highlightspodcast is now available to listen to below. DDWs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following World Cancer Day on 4 February , the news round-up this week focuses on new approaches to the treatment of cancer, including radiopharmaceuticals, programmable cell depletion and preventative vaccines.
NIH indirect funding cuts appals medical research groups
pharmaphorum
FEBRUARY 10, 2025
Billions of dollars will be cut from medical research funding provided by the NIH in the latest money-saving programme from the Trump administration.
Let's personalize your content